Case Study : Pacific Bioscience Laboratories, Inc.

Biometra is a small company based in the Boston suburb of Woburn which was recently acquired by Scientific Materials (SciMat), in order to deepen its portfolio in vascular medical devices. Biometra focused chiefly on catheters, or tubes used to drain or inject fluids or to allow access of surgical instruments for medical procedures. The catheter would be the first product ever launched by Biometra and so its success was critical for both the companies.

On the figure above, we can see that the terminal value is used as the horizon in forecasting the three projects. We also have to consider the condition of when we should set the terminal value. The key to set the horizon is when the stable growth of forecasted cash flows begin. When the stable growth begins, stop forecasting the

1. In no more than one-page, describe Biometra and the industry that this company is in.

Standard Level Biology Design Lab: How do Smarties and M&Ms compare when examined in 5 areas: mass, shell solubility, volume, density, and nutrition facts?

After conducting in-depth financial analysis of SubtleWax, we were able to identify and pinpoint all future costs associated with the creation, manufacturing, and selling of our product. When interpreting the data for the cost analysis (Exhibit ), the product cost per unit (12 strips) totals $3.22. This is comprised of 3 sub-costs: $2.12 of direct material, $0.70 of direct labour, and $0.37 of manufacturing overhead. Furthermore, to get a sense of period costs and total product costs, we conducted an industry analysis in order to project revenue. As of 2017, the hair removal market was valued at approximately $880 million. This market is mainly made up of direct competitors that include wax strip products, wax solutions, and wax beans. Due to the amount

Companies have to take into consideration the factors of safety to consumers and the environment, efficacy, sustainable sourcing of materials and costs. Exfoliants with jojoba beads, for example, are more expensive to produce.

Clorox could adopt a mix of a cost effective and differentiation strategy for its ecological products. Cost cutting could be in the form of decreasing the quantity per unit or consolidating the current product line. Additionally, the management mentioned internationalization as one of the targets of the centennial strategy. The company can look to penetrate the developing economies with their established primary brands such as Pine-sol, Formula 409 as these products have reached maturity in the US. Their low prices and effectiveness can help the company’s global aspirations along with supporting the long-term strategy by keeping the sales and revenues consistent.

Richcore Lifesciences is an innovative biotechnology company that works on the conservation of water, food and energy by providing various eco-friendly enzyme solutions. Some of the Animal Origin Free recombinant proteins it works on include Recombinant Trypsin, Recombinant Human Albumin and Recombinant cell dissociation agent. It also provides blends and supplements for the global nutraceuticals

Based in Davis, Calif., with additional facilities in Seattle, Wash. and Phoenix, Ariz., Arcadia Biosciences is focused on developing agricultural products that benefit the environment and enhance human health. Arcadia’s agronomic performance traits, including Nitrogen Use Efficiency, Water Use Efficiency, Salinity Tolerance, Heat Tolerance and Herbicide Tolerance, are all aimed at making agricultural production more economically efficient and environmentally sound. Arcadia’s nutrition technologies and products are aimed at creating healthier ingredients and whole foods with lower production costs. The company was recently listed in the Global Cleantech 100, representing the most innovative and promising ideas in clean technology, and was previously

In 1998, Biopure Corporation is one of the three legitimate contenders in the emerging field of “blood substitutes”. Biopure has invested $200M on the R&D on blood substitutes in the past with its primary goal being the development of a human blood substitute ( Hemopure) but Its entry into animal market (Oxyglobin) had been some

The Ads for the Sonicare toothbrush use three main appeals. They seem repeated all over the ads which are the appeals of aesthetic sensations, appeals of the need for prominence, and appeals to the need to achieve. Sonicare target the middle and higher class and the middle age. The Sonicare electronic toothbrush is used to clean teeth and gums, it does a better job than the manual brushes. It has a timer to ensure cleaning well in each quarter of the mouth.Through the frequent use of appeals to the need to achieve and appeals for prominence, and using a character with straight, bright teeth to demonstrate the benefit of using Sonicare tooth brush, Sonicare seems to target middle age and middle, upper class and people looking for whiter and healthier teeth.

Synapse Biomedical Inc. was founded in 2002, and is based in Oberlin, Ohio USA. The company commercializes NeuRx diaphragm pacing system, which uses a slightly invasive outpatient procedure to create a deeper and more comfortable breathing pattern. It improves the lives of individuals with neurological impairment, such as spinal cord injury, Amyotrophic Lateral Sclerosis–Lou Gehrig’s disease, and

The United States, Mexican and Chinese markets all took very different approaches to the release of Colgate-Palmolive’s (CP) newest oral care product in 2004-2005. The new toothpaste is called Colgate Max Fresh (CMF). It is a cavity preventing gel with breath-freshening strips suspended in it that dissolve while consumers brush their teeth. The technology behind the breath strips is patented, and Colgate was hoping the product would be a big success by providing unique freshness.

In the highly competitive Japanese skin-care market, P&G¡¦s new SK-II product has proven its success as a premium and prestige offering. P&G has gained significant knowledge transfers from SK-II development and further, has successfully tapped the fickle Japanese market and has devloped a loyal user-base in Taiwan and Hong Kong. With its phenomenal success, it is only logical that P&G consider rolling-out the SK-II product-line to the international market. However, while there is significant worldwide growth potential within the $9 billion prestige skin-care industry, based on recent organizational changes, new corporate priorities, and thorough market assessment, P&G must base its decision on current resources and capabilities to

The Bayer Corporation was founded in Friedrich Bayer in 1863. The company’s first product was aspirin and it was widely successful and is still sold today. Their next major drug the company produced was diacetylmorphine, also known as heroin. Bayer trademarked the name ”heroin” and sold the drug as a cough suppressant and non-addictive alternative to morphine in the early 1900s. Now the company is a multinational, pharmaceutical and life sciences company based out of Leverkusen, Germany. They handle a very wide berth of markets and so the company is structured in divisions. These divisions include Pharmaceuticals, Consumer Health, Crop Science, Animal Health. Pertaining to healthcare the company creates a variety of products, some of the